A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoprotein.
Abu-Shmais AA, Guo L, Khalil AM, Miller RJ, Janke AK, Vukovich MJ, Bass LE, Suresh YP, Rush SA, Wolters RM, Kose N, Carnahan RH, Crowe JE, Bonami RH, Mousa JJ, McLellan JS, Georgiev IS.
Abu-Shmais AA, et al. Among authors: guo l.
bioRxiv [Preprint]. 2024 Nov 1:2024.10.31.621295. doi: 10.1101/2024.10.31.621295.
bioRxiv. 2024.
PMID: 39554078
Free PMC article.
Preprint.